OBJECTIVES: To describe the development of atopic dermatitis (AD) during the first 3 years of life and identify the localization of the early skin lesions that predicts the development of AD. DESIGN: Prospective, longitudinal, birth cohort study of children born to mothers with a history of asthma, followed up for 3 years with scheduled visits every 6 months as well as visits for onset or acute exacerbations of skin symptoms. SETTING: The cohort was recruited from greater Copenhagen, Denmark, and followed up at a clinical research unit, which controlled all diagnoses and treatment of skin diseases. PARTICIPANTS: A total of 411 infants were enrolled in the cohort; 55 had incomplete follow-up and were excluded from certain analyses. MAIN OUTCOME MEASURES: Atopic dermatitis was defined based on the criteria of Hanifin and Rajka, and severity was assessed by the SCORAD (Scoring Atopic Dermatitis) index. Predictive odds ratios of early skin lesions for those who developed AD vs those who did not were calculated. RESULTS: The cumulative incidence of AD by age 3 years was 44% (155/356). The prevalence rate peaked at age 2 years for boys and at age 2.5 years for girls, but there were no other sex differences in the proportion of children developing AD. Skin involvement in infants with AD was found to begin at the scalp, forehead, ear, and neck in a balaclava-like pattern and continue to the extensor sides and trunk, finally affecting the flexor sides of the extremities. Early skin lesions of arms and joints best predicted AD at age 3 years. CONCLUSIONS: Atopic dermatitis begins at the scalp, forehead, ear, and neck in a balaclava-like pattern. Eczema at the arms and joints provides the highest predictive value for the development of AD at age 3 years. This may be used for early prediction and intervention of AD.
OBJECTIVES: To describe the development of atopic dermatitis (AD) during the first 3 years of life and identify the localization of the early skin lesions that predicts the development of AD. DESIGN: Prospective, longitudinal, birth cohort study of children born to mothers with a history of asthma, followed up for 3 years with scheduled visits every 6 months as well as visits for onset or acute exacerbations of skin symptoms. SETTING: The cohort was recruited from greater Copenhagen, Denmark, and followed up at a clinical research unit, which controlled all diagnoses and treatment of skin diseases. PARTICIPANTS: A total of 411 infants were enrolled in the cohort; 55 had incomplete follow-up and were excluded from certain analyses. MAIN OUTCOME MEASURES: Atopic dermatitis was defined based on the criteria of Hanifin and Rajka, and severity was assessed by the SCORAD (Scoring Atopic Dermatitis) index. Predictive odds ratios of early skin lesions for those who developed AD vs those who did not were calculated. RESULTS: The cumulative incidence of AD by age 3 years was 44% (155/356). The prevalence rate peaked at age 2 years for boys and at age 2.5 years for girls, but there were no other sex differences in the proportion of children developing AD. Skin involvement in infants with AD was found to begin at the scalp, forehead, ear, and neck in a balaclava-like pattern and continue to the extensor sides and trunk, finally affecting the flexor sides of the extremities. Early skin lesions of arms and joints best predicted AD at age 3 years. CONCLUSIONS:Atopic dermatitis begins at the scalp, forehead, ear, and neck in a balaclava-like pattern. Eczema at the arms and joints provides the highest predictive value for the development of AD at age 3 years. This may be used for early prediction and intervention of AD.
Authors: Sunna Thorsteinsdottir; Jakob Stokholm; Jacob P Thyssen; Sarah Nørgaard; Jonathan Thorsen; Bo L Chawes; Klaus Bønnelykke; Johannes Waage; Hans Bisgaard Journal: JAMA Dermatol Date: 2019-01-01 Impact factor: 10.282
Authors: Tosha Ashish Kalhan; Evelyn Xiu Ling Loo; Lynette Pei-Chi Shek; Michael S Kramer; Carolina Un Lam; Bindu Karunakaran; Hugo Van Bever; Anne Goh; Yap Seng Chong; Bee Wah Lee; Kok Hian Tan; Seang Mei Saw; Keith M Godfrey; Chin-Ying Stephen Hsu Journal: Pediatr Allergy Immunol Date: 2021-10-19 Impact factor: 5.464
Authors: Adrian J Lowe; Mimi Lk Tang; Shyamali C Dharmage; George Varigos; Della Forster; Lyle C Gurrin; Colin F Robertson; Michael J Abramson; Katrina J Allen; John Su Journal: BMC Dermatol Date: 2012-04-04
Authors: Philip J Cooper; Martha E Chico; Irene Guadalupe; Carlos A Sandoval; Edward Mitre; Thomas A E Platts-Mills; Mauricio L Barreto; Laura C Rodrigues; David P Strachan; George E Griffin Journal: BMC Infect Dis Date: 2011-06-29 Impact factor: 3.090
Authors: Charlotte Giwercman Carson; Liselotte Brydensholt Halkjaer; Signe Marie Jensen; Hans Bisgaard Journal: PLoS One Date: 2012-08-15 Impact factor: 3.240
Authors: Hans Bisgaard; Angela Simpson; Colin N A Palmer; Klaus Bønnelykke; Irwin McLean; Somnath Mukhopadhyay; Christian B Pipper; Liselotte B Halkjaer; Brian Lipworth; Jenny Hankinson; Ashley Woodcock; Adnan Custovic Journal: PLoS Med Date: 2008-06-24 Impact factor: 11.069